Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsShares Issued
Ratios

Amylyx Pharmaceuticals (AMLX) Long-Term Debt Issuances (2021 - 2025)

Historic Long-Term Debt Issuances for Amylyx Pharmaceuticals (AMLX) over the last 2 years, with Q3 2025 value amounting to $191.1 million.

  • Amylyx Pharmaceuticals' Long-Term Debt Issuances changed N/A to $191.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $256.7 million, marking a year-over-year change of. This contributed to the annual value of $11.9 million for FY2021, which is 1216.27% up from last year.
  • Latest data reveals that Amylyx Pharmaceuticals reported Long-Term Debt Issuances of $191.1 million as of Q3 2025.
  • Amylyx Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $191.1 million during Q3 2025, with a 5-year trough of $11.9 million in Q1 2021.